ACADIA Pharmaceuticals Inc
(NASDAQ: ACAD)
+0.37+2.76%Today's Close
|
13.76
-0.03
-0.22%
After hours
ACADIA Pharmaceuticals Inc, a small-cap unknown style company in the health care sector, is expected to match the market over the next six months with very high risk.
10 is the best possible rating.
Previous day's closing price for ACAD was significantly above its 50-day moving average. Very positive
Earnings growth in the past year is holding steady compared to earnings growth in the past three years. Neutral
ConThe price-to-earnings multiple is a negative number. No effect
One or more analysts has modestly decreased quarterly earnings estimates for ACAD. Negative
The most recent quarterly earnings report was approximately equal to or higher than analysts’ consensus forecast, but not to a degree that is predictive of future returns. Neutral
Earnings growth in the past year is holding steady compared to earnings growth in the past three years. Neutral
One or more analysts has modestly decreased quarterly earnings estimates for ACAD. Negative
An executive, director or major shareholder sold a small number of shares recently. Neutral
Shares are under heavy accumulation by financial institutions. Positive for a small company like ACAD
The price-to-earnings multiple is a negative number. No effect
Price-to-sales information is unavailable or inconsistent.
The ratio of ACAD's price-to-earnings multiple to its five-year growth rate is unavailable or inconsistent.
The StockScouter measure of relative price change and consistency is flat. Neutral
Previous day's closing price for ACAD was significantly above its 50-day moving average. Very positive
data provided by Verus Analytics
Learn more about the StockScouter rating system.
Page generated 5/23/2013 5:54 PM ET
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
